Disability News, Benefits, and Health Resources
Seventy million American adults live with a disability. Another 1.3 billion people worldwide (about the combined population of Europe and North America) share that experience, roughly 16 percent of the global population.
Disabled World (DW), also known to many readers as Disability World, reports on the policies, research, benefits, and assistive technology that shape their lives. Coverage centers on the United States: Social Security and SSI payments, Medicare and Medicaid rules, accessibility law, and medical research relevant to American readers. International stories appear where they intersect with American policy or practice. Disabled World has been publishing since 2004 under the banner Towards Tomorrow. Learn more about us.
"Disability is the only minority group that anyone can join at any time." - a widely shared saying in the disability community, often attributed to American comedian Josh Blue.
Jump To:
Popular | News | Updated
Popular Pages
- Disability Loans and Grants: Financial assistance programs available for low-income families, seniors, and disabled students.
- Famous People with Disabilities: Lists of well-known people with various disabilities and conditions who contributed to society.
- Disability and Health Statistics: Data, charts and facts on prevalence, demographics and trends.
- Awareness Ribbon Colors: Guide to awareness ribbon colors for health, medical conditions, disability, and other causes.
- Adult Height to Weight Chart: Ideal weight-to-height ratio for adult females and males.
- Child to Teen Height to Weight Ratio Charts: Average height-to-weight ratios for children and teens organized by age.
Recent Disability News and Information
Disability Pluralism: Understanding Many Ways of Being Human
Pluralism in disability explained: how the social model, the UN CRPD, Deaf culture and neurodiversity frame disability as a valued part of human diversity. Published: 31 Oct 2026.
Paper2Audio: AI Text-to-Speech App for Documents and Books
Paper2Audio is an AI text-to-speech app that turns PDFs, research papers, textbooks and ebooks into natural audio for people with dyslexia, ADHD or low vision. Published: 30 Oct 2026.
Kim Peek: Savant Memory, Disability and Measuring Ability
Kim Peek, the savant who inspired Rain Man, shows why exceptional memory, daily dependence and intelligence need to be assessed as separate human abilities. Published: 30 Oct 2026.
Captio AI: Live Captions App That Shows Who Is Speaking
Captio AI is a live captions app for iPhone, iPad and Android that captions speech in 60 languages and shows deaf and hard of hearing users who is speaking. Published: 27 Oct 2026.
Zhangjiajie for Seniors: Seeing the Peaks Without Climbing
A Zhangjiajie tour operator explains how seniors and travelers with limited mobility can see the peaks by elevator, cable car and eco-bus with less climbing. Published: 27 Oct 2026.
Marla Runyan: Elite Racing With Stargardt Vision Loss
Marla Runyan, Paralympic champion and two-time Olympian with Stargardt disease, raced at elite speed with central vision loss and incomplete visual information. Published: 27 Oct 2026.
Famous Savants: Notable People With Savant Syndrome
A list of famous savants, from Kim Peek to Stephen Wiltshire, with the musical, artistic, memory and acquired skills that define Savant Syndrome. Published: 25 Oct 2026.
Savant vs Savant Syndrome: Meaning, Causes and Examples
Learn what a savant is, what savant syndrome means, how the two terms differ, and why islands of genius can appear alongside autism or brain injury. Published: 25 Oct 2026.
Newly Updated Pages
Integrating Social Media in the Humanities Online Classroom: Learn how to use social media in humanities classrooms to boost engagement and accessibility .
Increased Angiogenesis Linked to Poor Survival Rates in Ovarian Cancer Patients: Increased angiogenesis and vascular endothelial growth factor expression associated with poor survival in women with sex cord-stromal ovarian tumors.
Naltrexone Offers Promise for MS but Lacks Access: Low-dose naltrexone shows promise in halting MS progression and improving quality of life, but patients struggle to access the treatment due to lack of clinical trials.